Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...
Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...
Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
More than 200 community health agents have already been trained in Burundi to help control the spread of mpox as the ...
Tanzania recently reported its first two mpox cases, raising the number of affected countries to 23, officials from the ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
In eastern Congo, mpox detection and treatment face setbacks amid a rebel offensive backed by Rwanda. Hospitals suffer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results